Kenalog-10 (triamcinolone acetonide, injectable suspension, USP), 10-mg/mL, 5-mL multi-dose vial

Kenalog-10 Injection (triamcinolone acetonide injectable suspension, USP) is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis.

Possible side effects may include allergic reactions (labored breathing, hives, etc), increased blood pressure, sudden weight gain, increased intake of water, increased urination, and decreased immune system.

The following drug interactions have either been reported or are theoretical in humans or animals receiving triamcinolone and may be of significance in veterinary patients: Amphotericin B, analgesics, anticholinestearase, aspirin, barbbiturates, bupropion, cyclophosphamide, cyclosporine, and digoxin. Contact your veterinarian for a full list.

There may be decreased resistance and inability to localize infection when corticosteroids are used. Infection with any pathogen (viral, bacterial, fungal, protozoan, or helminthic) in any location of the body may be associated with the use of corticosteroids alone or in combination with other immunosuppressive agents.

This drug is FDA-approved for human use. However, it is common practice for veterinarians to prescribe such drugs for use in dogs and cats.